Adicet Bio
ACET
ACET
84 hedge funds and large institutions have $48.9M invested in Adicet Bio in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
46% less capital invested
Capital invested by funds: $90.4M → $48.9M (-$41.5M)
87% less call options, than puts
Call options by funds: $9K | Put options by funds: $70K
Holders
84
Holding in Top 10
–
Calls
$9K
Puts
$70K
Top Buyers
| 1 | +$1.9M | |
| 2 | +$684K | |
| 3 | +$639K | |
| 4 |
Two Sigma Advisers
New York
|
+$386K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$341K |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$1.74M | |
| 3 | -$1.72M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.39M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$441K |